ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Diffuse alveolar damage,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
2,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
4,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
6,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
6,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
6,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
8,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
8,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
9,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
10,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,1,Large intestine infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
12,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
12,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
12,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
12,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
13,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
13,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,Y
14,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
15,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
15,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
15,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
16,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
16,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
17,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
18,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
18,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
18,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
18,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
18,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
19,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
20,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
20,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
21,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
21,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
22,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
22,2,Intervertebral discitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
23,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
23,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
24,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
24,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
24,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
25,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
25,2,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
25,3,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
26,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
26,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
27,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
27,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
28,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
28,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
28,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
28,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
28,5,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
29,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
29,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
29,3,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
30,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
31,1,Alcoholic liver disease,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
31,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
32,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
32,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
33,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
34,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
34,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
34,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
34,4,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
35,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
36,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
36,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
36,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
36,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
37,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
37,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
37,3,Volvulus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
38,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
38,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
38,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
38,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
38,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
38,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
38,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
39,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
39,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
40,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
41,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
42,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
42,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
42,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
43,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
43,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
43,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
43,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
44,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
44,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
45,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
46,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
47,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
48,1,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
49,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
49,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
49,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
49,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
50,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
51,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
51,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
52,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
53,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
53,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
53,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
54,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
54,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
54,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
55,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
55,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
56,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
56,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
56,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
56,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
57,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
58,1,Monocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
58,2,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
59,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
60,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
61,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
61,2,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
61,3,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
62,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
62,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
63,1,Chronic lymphocytic leukaemia transformation,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
64,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
65,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
65,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
65,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
66,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
66,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
67,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
68,1,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
68,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
69,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
69,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
69,3,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
70,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
71,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
71,2,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
72,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
73,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
74,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
75,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
75,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
75,3,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
75,4,Large intestine polyp,Benign neoplasms gastrointestinal (excl oral cavity),Benign neoplasms gastrointestinal,Gastr,N
75,5,Lymph node palpable,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
75,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
75,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
76,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
76,2,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
77,1,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
78,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
78,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
78,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
78,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
78,5,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
78,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
78,7,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
79,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
79,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
79,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
79,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
80,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
80,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
81,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
81,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
82,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
83,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
83,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
84,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
84,2,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
84,3,Lymphocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
84,4,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
85,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
86,1,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
86,2,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
86,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
86,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
86,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
87,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
88,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
88,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
89,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
90,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
91,1,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,N
91,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
92,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
92,2,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
93,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
93,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
94,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
94,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
95,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
96,1,Campylobacter infection,Campylobacter infections,Bacterial infectious disorders,Infec,N
96,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
96,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
97,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
98,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
99,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
99,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
100,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
100,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
100,3,International normalised ratio fluctuation,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
101,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
101,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
102,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
102,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
102,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
103,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
103,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
103,3,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
103,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
104,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
104,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
105,1,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
106,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
106,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
107,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
107,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
108,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
108,2,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
108,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
108,4,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
108,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
109,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
109,2,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
109,3,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
110,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
110,2,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
110,3,International normalised ratio abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
110,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
110,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
111,1,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
112,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
112,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
112,3,Right ventricular failure,Right ventricular failures,Heart failures,Card,Y
113,1,B-cell prolymphocytic leukaemia,B-cell small lymphocytic lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
113,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
114,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
115,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
115,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
116,1,Limb operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
117,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
117,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
118,1,Empyema,Infections NEC,Infections - pathogen unspecified,Infec,N
119,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
120,1,Enterocolitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
121,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
122,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
122,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
122,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
122,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
123,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
123,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
124,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
124,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
124,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
124,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
125,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
125,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
126,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
126,2,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
126,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
126,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
126,5,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
126,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
127,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
127,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
127,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
128,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
128,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
128,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
129,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
129,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
130,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
130,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
130,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
131,1,Cholangiocarcinoma,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
132,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
132,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
133,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
133,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
134,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
135,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
135,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
136,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
136,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
137,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
138,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
138,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
139,1,Atypical pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
139,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
139,3,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
139,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
140,1,Sinusitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
141,1,Lower respiratory tract infection fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
142,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
143,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
144,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
144,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
144,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
145,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
